Gene transfer of a hybrid interleukin-1β gene to B16 mouse melanoma recruits leucocyte subsets and reduces tumour growth in vivo

Cancer Immunology Immunotherapy

Volumn 44, Issue 5, 1997, Pages 273-281

  Björkdahl, Olle ^a   Wingren, Anette Gjörloff ^a   Hedlund, Gunnar ^a,b   Ohlsson, Lennart ^b   Dohlsten, Mikael ^a  

^a LUND UNIVERSITY   (Sweden)

^b Pharmacia & Upjohn AB   (Sweden)

Author keywords

IL 1 release; Signal sequence; Tumour growth inhibition

Indexed keywords

CD4 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE TRANSFER; MACROPHAGE; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; DENDRITIC CELLS; FLOW CYTOMETRY; GENETIC ENGINEERING; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; MACROPHAGES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PROTEIN SORTING SIGNALS; SURVIVAL ANALYSIS; T-LYMPHOCYTE SUBSETS;

EID: 0030748450     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050383     Document Type: Article

References (39)

1. Altmann DM, Hogg N, Trowsdale J, Wilkinson D (1989) Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen presenting cell functions in mouse L cells. Nature 338:512-514
2. Apte RN, Douvdevani A, Zoller M, White RM, Dvorkin T, Shimoni N, Fima E, Hasham M, Huleihel M, Benharroch D, Voronov E, Segal S (1994) Cytokine-induced tumour immunogenicity: endogenous interleukin-1α expressed by fibrosarcoma cells confers reduced tumorigenicity. Immunol Lett 39:45-52
3. Arend WP (1993) Interleukin-1 receptor antagonist. Adv Immunol 54:167-227
4. Asher AL, Mule JJ, Kasid A, Restifo NP, Salo JC, Reishert CM, Jaffe G, Fendly B, Kreigler M, Rosenberg SA (1991) Murine tumor cells transduced with the gene for tumour necrosis factor-α. J Immunol 146:3227-3234
5. Auron PE, Webb AC, Rosenwasser LJ, Mucci SF, Rich A, Wolf SM, Dinarello CA (1984) Nucleotide sequence of human monocyte interleukin 1 precursor complementary DNA. Proc Natl Acad Sci USA 81:7907-7911
6. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS. Gimbrone MA (1987) Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 84:9238-9242
7. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizarro LA, Huebner K, Black RA (1992) Molecular cloning of the interleukin-1β converting enzyme. Science 256:97-100
8. Colombo MP, Forni G (1994) Cytokine gene transfer in tumour inhibition and tumour therapy: where are we now? Immunol Today 15:48-51
9. Colotta F, Dower SK, Sims JE, Mantovani A (1994) The type II "decoy" receptor: a novel regulatory pathway for interleukin 1. Immunol Today 15:562-566
10. Colotta F, Orlando S, Fadlon EJ, Sozzani S, Matteucci C, Mantovani A (1995) Cheinoattractants induce rapid release of interleukin-1 type II decoy receptor in human polymorphonuclear cells. J Exp Med 181:2181-2188
11. Dempsey RA, Dinarello C, Mier J, Rosenwasser L, Allegretta M, Brown T, Parkinson D (1982) The different effects of human leukocyte pyrogen/lymphocyte-activating, T cell growth factor, and interferon on human natural killer activity. J Immunol 129:2504-2510
12. Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652
13. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumour cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumour immunity. Proc Natl Acad Sci USA 90:3539-3543
14. Fidler IJ (1975) Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res 35:218-224
15. + T cells require a costimulatory signal mediated through the LFA-1/ICAM-1 pathway. J Immunol 148:1993-1998
16. Gjörloff Wingren A, Björkdahl O, Labuda T, Björk L, Andersson U, Gullberg U, Hedlund G, Sjögren HO, Kalland T, Widegren B, Dohlsten M (1996) Fusion of a signal sequence to the Interleukin-1β gene directs the protein from cytoplasmic accumulation to extracellular release. Cell Immunol 169:226-237
17. Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM (1991) Treatment of established renal cancer by tumour cells engineered to secrete interleukin-4. Science 254:713-716
18. Hawley RG, Wang MH, Fong AZC, Hawley TS (1993) Association between ICAM-1 expression and metastatic capacity of murine B-cell hybridomas. Clin Exp Metastasis 11:213-226
19. + T cell-dependent tumour rejection. J Exp Med 174:1291-1298
20. Hogquist KA, Nett MA, Unanue ER, Chaplin DD (1991) Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA 88:8485-8489
21. Hogquist KA, Unanue ER, Chaplin DD (1991) Release of IL-1 from mononuclear phagocytes. J Immunol 147:2181-2186
22. Howard AD, Kostura MJ, Thornberry N, Ding GJF, Limjuco G, Weider J, Salley JP, Hogquist KA, Chaplin DD, Mumford RA, Schmidt JA, Tocci MJ (1991) IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1β precursor at two distinct sites and does not cleave 31-kDa IL-1α. J Immunol 147:2964-2969
23. Hsu FJ, Benike C, Fagnoni F, Lues TM, Czerwinski D, Taidi B, Engleman EG, Levy R (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2:52-58
24. Johnson CW, Barth RF, Adams D, Holman B, Price JE, Sautins I (1987) Phenotypic diversity of murine B16 melanoma detected by anti-B16 monoclonal antibodies. Cancer Res 47:1111-1117
25. Johnson JP, Stade BG, Holzmann B, Schwable W, Riethmuller G (1989) De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 86:641-644
26. Kenney JS, Masada MP, Eugui EM, Delustru BM, Mulkins MA, Allison AC (1987) Monoclonal antibodies to human recombinant interleukin 1 (IL-1)β: quantitation of IL-1β and inhibition of biological activity. J Immunol 138:4236-4242
27. Knight SC, Hunt R, Dore C, Medawar PB (1985) Influence of dendritic cells on tumour growth. Proc Natl Acad Sci USA 82:4495-4497
28. Lachman LB, Dinarello CA, Llansa ND, Fidler IJ (1986) Natural and recombinant human interleukin-1β is cytotoxic for melanoma cells. J Immunol 136:3098-3102
29. Markowitz D, Goff S, Bank A (1988) A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 62:1120-1124
30. Miura M, Zhu H, Rotello R, Hartweig EA, Juan J (1993) Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653-660
31. Onozaki K, Matsushima K, Saito T, Kleinerman E, Oppenheim JJ (1994) Role of interleukin-1 and prostaglandin E in human monocyte mediated tumour toxicity. Lymphokine Rep 3:263
32. Osborn L, Hession C, Tizard R, Vasallo C, Luhowskyj S, Chi-Rosso G, Lobb R (1989) Direct expression cloning of vascular cell adhesion molecule 1, a cytokine induced endothelial protein that binds to lymphocytes. Cell 59:1203-1211
33. Pober JS, Gimbrone MA, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA (1986) Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 137:1893-1896
34. Porgador A, Bannerji R, Watanabe Y, Feldman M, Gilboa E, Eisenbach L (1993) Antimetastatic vaccination of tumour-bearing mice with two types of IFN-γ gene-inserted tumour cells. J Immunol 150:1458-1470
35. Smith JW, Longo DL, Alvord WG, Janik JE, Sharfman WH, Gause BL, Curti BD, Creekmore SP, Holmlund JT, Fenton RG, Sznol M, Miller LL, Shimizu M, Oppenheim JJ, Fiem SJ, Hursey JC, Powers GC, Urba WJ (1993) The effect of treatment with interleukin-1α on platelet recovery after high-dose carboplatin. N Eng J Med 328:756-761
36. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller FJ, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJF, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin T, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, Tocci MJ (1992) A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356:768-774
37. Vieveg J, Rosenthal FM, Bannerji R, Heston WDW, Fair WR, Gansbacher B, Gilboa E (1994) Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumour vaccines.Cancer Res 54:1760-1765
38. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75:641-652
39. Zöller M, Douvdevani A, Segal S, Apte RN (1992) Interleukin-1 production by transformed fibroblasts. II. Influence on antigen presentation and T-cell-mediated anti-tumour response. Int J Cancer 50:450-457